Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-EN Version v12-FR
Language English French
Date Updated 2023-05-26 2023-05-24
Drug Identification Number 02437899 02437899
Brand name SAXENDA SAXENDA
Common or Proper name SAXENDA SAXENDA
Company Name NOVO NORDISK CANADA INC NOVO NORDISK CANADA INC
Ingredients LIRAGLUTIDE LIRAGLUTIDE
Strength(s) 6MG 6MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5x3M: 5x3M:
ATC code A10BJ A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-05-19 2023-05-19
Actual start date 2023-05-19 2023-05-19
Estimated end date 2023-05-25 2023-05-24
Actual end date 2023-05-25
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments We anticipate wholesalers will have enough stock on hand to cover the demand until the delayed shipment is received We anticipate wholesalers will have enough stock on hand to cover the demand until the delayed shipment is received
Health Canada comments